🔎 Trials Near Me

Hem › Diffus intrinsik pontin gliom › Texas

Kliniska studier för Diffus intrinsik pontin gliom i Texas

11 studier för Diffus intrinsik pontin gliom söker deltagare vid platser i Texas.

Städer i Texas

Officiell studietext (engelska)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Texas Children's Hospital, Houston
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 21 sep. 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • Cook Children's Medical Center, Fort Worth
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 11 sep. 2026 · NCT04870944

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

  • The University of Texas M. D. Anderson Cancer Center, Houston
RekryterarFas 1
36 Months · Alla kön · Uppdaterad 9 sep. 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

  • Texas Children's Hospital, Houston
RekryterarObservationsstudie
12 Months – 39 Years · Alla kön · Uppdaterad 8 sep. 2026 · NCT05839379

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Children's Medical Center, Dallas
RekryterarFas 1/2
Upp till ålder 26 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06465199

Study of Olutasidenib and Temozolomide in HGG

  • Texas Children's Hospital, Houston
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Texas Children's Hospital, Houston
RekryterarFas 2
Ålder 3 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05096481

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

  • Texas Children's Hospital, Houston
RekryterarFas 1
12 Months – 25 Years · Alla kön · Uppdaterad 3 aug. 2026 · NCT04099797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Texas Children's Hospital, Houston
RekryterarTidig fas 1Friska volontärer välkomna
Ålder 1 till 21 · Alla kön · Uppdaterad 29 juni 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Texas Children's Hospital, Houston
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 29 maj 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Texas Children's Hospital, Houston
RekryterarTidig fas 1
Upp till ålder 21 · Alla kön · Uppdaterad 18 mars 2026 · NCT04655404

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.